The thing hampering efforts to quell the ongoing Ebola outbreak in Africa and treat Kent Brantly and Nancy Writebol, two Americans with the disease now at Emory University Hospital in Georgia, is that the FDA has approved no medications or therapies specific to Ebola. Researchers and laboratories around the world are working to change that.